Healthcare provider profile · identity verified

Anthony B Hardt, MD

Family Practice · VIRGINIA BEACH, VA · NPI 1679548051

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	529	175
Amlodipine Besylate	Amlodipine Besylate	404	129
Levothyroxine Sodium	Levothyroxine Sodium	264	79
Lisinopril	Lisinopril	245	75
Losartan Potassium	Losartan Potassium	217	69
Simvastatin	Simvastatin	161	51
Metformin Hcl	Metformin Hcl	137	39
Zolpidem Tartrate	Zolpidem Tartrate	126	30
Metoprolol Succinate	Metoprolol Succinate	122	38
Alprazolam	Alprazolam	113	35
Rosuvastatin Calcium	Rosuvastatin Calcium	112	39
Hydrochlorothiazide	Hydrochlorothiazide	106	34
Omeprazole	Omeprazole	106	31
Escitalopram Oxalate	Escitalopram Oxalate	92	30
Pantoprazole Sodium	Pantoprazole Sodium	92	38
Albuterol Sulfate Hfa	Albuterol Sulfate	76	22
Tamsulosin Hcl	Tamsulosin Hcl	75	29
Carvedilol	Carvedilol	74	19
Furosemide	Furosemide	73	25
Metoprolol Tartrate	Metoprolol Tartrate	72	23
Eliquis	Apixaban	71	21
Ezetimibe	Ezetimibe	70	21
Gabapentin	Gabapentin	69	22
Allopurinol	Allopurinol	63	19
Sertraline Hcl	Sertraline Hcl	59	23
Fluticasone Propionate	Fluticasone Propionate	52	25
Clopidogrel	Clopidogrel Bisulfate	51	16
Potassium Chloride	Potassium Chloride	49	21
Finasteride	Finasteride	44	17
Xarelto	Rivaroxaban	42	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	12
Lorazepam	Lorazepam	39	suppressed
Glimepiride	Glimepiride	38	12
Montelukast Sodium	Montelukast Sodium	38	15
Trazodone Hcl	Trazodone Hcl	37	12
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Valacyclovir	Valacyclovir Hcl	35	16
Atenolol	Atenolol	33	suppressed
Januvia	Sitagliptin Phosphate	32	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	12
Famotidine	Famotidine	28	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Jardiance	Empagliflozin	26	suppressed
Klor-Con M20	Potassium Chloride	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Naproxen	Naproxen	24	11
Synthroid	Levothyroxine Sodium	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Ozempic	Semaglutide	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	15
Spironolactone	Spironolactone	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	12
Diazepam	Diazepam	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Cephalexin	Cephalexin	15	14
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Prednisone	Prednisone	13	11
Clonidine Hcl	Clonidine Hcl	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Prasugrel Hcl	Prasugrel Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error